HBIO
Harvard Bioscience IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$24.15M
P/E Ratio
—
EPS
$-12.80
Beta
1.50
52W High
$9.46
52W Low
$2.81
50-Day MA
$5.39
200-Day MA
$5.40
Dividend Yield
—
Profit Margin
-65.50%
Forward P/E
15.06
PEG Ratio
1.31
About Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery, and preclinical testing for drug development. The company is headquartered in Holliston, Massachusetts.
Fundamentals
| Revenue (TTM) | $86.55M |
| Gross Profit (TTM) | $49.91M |
| EBITDA | $7.44M |
| Operating Margin | 14.00% |
| Return on Equity | -147.10% |
| Return on Assets | 0.91% |
| Revenue/Share (TTM) | $19.50 |
| Book Value | $3.07 |
| Price-to-Book | 1.69 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 0.68 |
| EV/EBITDA | 168.91 |
| Quarterly Earnings Growth (YoY) | -80.30% |
| Quarterly Revenue Growth (YoY) | -3.30% |
| Shares Outstanding | $4.47M |
| Float | $3.47M |
| % Insiders | 10.82% |
| % Institutions | 51.14% |
Analyst Ratings
Consensus ($6.00 target)
1
Buy1
HoldData last updated: 4/8/2026